Search

Search Constraints

You searched for: Author/Creator Everson, Gregory T.

Search Results

1. 821Daclatasvir and Asunaprevir Plus Peginterferon Alfa-2a and Ribavirin in Patients With HCV Genotype 1 or 4 Infection: Phase 3 HALLMARK-QUAD Results. (December 2014)

2. A randomized controlled trial of pretransplant antiviral therapy to prevent recurrence of hepatitis C after liver transplantation. Issue 5 (17th January 2013)

3. A randomized controlled trial of pretransplant antiviral therapy to prevent recurrence of hepatitis C after liver transplantation1234. Issue 5 (17th January 2013)

5. Clinical Research in Hepatology in the COVID‐19 Pandemic and Post‐Pandemic Era: Challenges and the Need for Innovation. Issue 5 (6th November 2020)

6. Daclatasvir + asunaprevir + beclabuvir ± ribavirin for chronic HCV genotype 1‐infected treatment‐naive patients. (6th December 2015)

7. Deterioration in liver function after liver‐directed therapy for hepatocellular carcinoma measured by cholate clearance. Issue 5 (3rd September 2020)

9. Elbasvir/Grazoprevir in People With Hepatitis C Genotype 1 Infection and Child-Pugh Class B Cirrhosis: The C-SALT Study. Issue 4 (April 2019)

10. Functional elements associated with hepatic regeneration in living donors after right hepatic lobectomy. Issue 3 (11th March 2013)